REG - Tate & Lyle PLC - Update to the Notice of AGM 2024

Tate & LyleAnnouncement

21/06/2024 14:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240621:nRSU4481Ta&default-theme=true

RNS Number : 4481T  Tate & Lyle PLC  21 June 2024

Tate & Lyle PLC

 

Update to the Notice of Annual General Meeting 2024

 

Further to our announcement on 4 June 2024 (1075R) of the publication of our
Annual Financial Report and Notice of Annual General Meeting 2024, Tate &
Lyle PLC ('the Company' or 'Tate & Lyle') announces that it will seek
approval for an additional resolution at the Annual General Meeting and has
submitted a revised Proxy Form to shareholders for this purpose.  The revised
Proxy Form has also been submitted to the National Storage Mechanism and will
shortly be available for inspection
at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

Proxy Form
- http://www.rns-pdf.londonstockexchange.com/rns/4481T_1-2024-6-21.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4481T_1-2024-6-21.pdf)

 

This revised form of proxy is being sent to shareholders further to the
announcement on 20 June 2024 of the proposed combination of the Tate &
Lyle and CP Kelco businesses. A copy of our announcement of this transaction
can be found at our website: www.tateandlyle.com.

 

The Proposed Transaction constitutes a Class 1 transaction for Tate & Lyle
under the UK Listing Rules and is, therefore, as at the date of this letter,
conditional on the approval of Tate & Lyle's shareholders.  As indicated
by the Financial Conduct Authority ("FCA"), the UK Listing Rules are expected
to change in the coming weeks, such that the requirement for a shareholder
meeting to vote to approve a Class 1 transaction would no longer apply.

 

At the present time, Tate & Lyle requires the permission of its
shareholders at a general meeting to change the name of the Company. In
contemplation of the changes to the Listing Rules as set out above, the Board
proposes to amend the Company's Articles of Association to permit the
directors to change the name of the Company should the Directors consider this
to be appropriate following the combination with CP Kelco.

 

Accordingly, the Directors have reissued the proxy card for the above AGM with
an additional resolution seeking shareholder approval for this proposed
amendment to the Articles.

 

It is proposed that the following resolution be passed as a special
resolution:

 

Resolution 23: to add a new Article 127 to the Articles of Association as
follows:

127 CHANGE OF NAME The Company may change its name by resolution of the
board.

 

Accordingly, shareholders should submit, or, if they have already voted,
resubmit their votes using the revised form of proxy.

 

The Annual General Meeting 2024 will be held at the Royal College for Nursing,
20 Cavendish Square, London, W1G 0RN at 10.30am on 25 July 2024.

 

The Annual Report 2024, Notice of Annual General Meeting 2024, Notice of
Availability, and Proxy Form are also available on the Company's
website: https://www.tateandlyle.com/news/2024-annual-report-and-notice-agm
(https://www.tateandlyle.com/news/2024-annual-report-and-notice-agm) . Mailing
of the Annual Report 2024, Notice of Annual General Meeting 2024, Notice of
Availability and Proxy Form to shareholders who have requested or are entitled
to receive them will occur shortly.

 

We will notify shareholders of any significant updates to our Annual General
Meeting 2024 arrangements via a regulatory information service and on the
Investors Hub section of the Company's website.

 

Claire-Marie O'Grady

Company Secretary

21 June 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMGZGZVFMZGDZM